Beta Bionics Chief Product Officer Mensinger Mike sold 2,650 shares at $22 per share. The transaction represented about 1.5% of his prior holding, leaving him with 177,390 shares, giving investors the disclosed size of the sale and his remaining position.

Key Highlights

  • Mensinger Mike sold 2,650 Beta Bionics shares.
  • The sale price was $22 per share on 16 September 2026.
  • Mensinger Mike owned 177,390 shares following the transaction.

Mensinger Mike, the company’s Chief Product Officer, sold 2,650 shares in the transaction. The disclosed price was $22 per share.

$22 Share Sale Completed on September 16

The transaction took place on 16 September 2026. The filing lists transaction code S. The sale covered 2,650 Beta Bionics (NASDAQ: BBNX) shares, with each share assigned a price of $22. Mensinger Mike was identified in the transaction as the company’s Chief Product Officer.

Post-Transaction Position Stood at 177,390 Shares

Following the transaction, Mensinger Mike’s reported position was 177,390 Beta Bionics shares. The sale amounted to about 1.5% of his prior shareholding. That percentage is stated against the position held before the transaction, while the 177,390-share figure describes the position afterward. The filing reports the 2,650-share sale and the 177,390-share post-transaction position. Transaction code S denotes an open-market or private sale.